Chandrasekhar Bal

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Systematic Review

Papillary Thyroid

Top Venues

European journal of nuclear medicine and molecular imaging

Clinical endocrinology

The Journal of clinical endocrinology and metabolism

Nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Mangu Srinivas Bharadwaj, Sanjana Ballal, Chandrasekhar Bal
Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events. The Journal of clinical endocrinology and metabolism (2024)
Swayamjeet Satapathy, Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, Chandrasekhar Bal
[ 177 Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study. European journal of nuclear medicine and molecular imaging (2024)
Swayamjeet Satapathy, Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, Chandrasekhar Bal
[ 177 Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study. European journal of nuclear medicine and molecular imaging 51 (8) (2024)
Swayamjeet Satapathy, Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, Chandrasekhar Bal
[ 177 Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study. European journal of nuclear medicine and molecular imaging 51 (8) (2024)
Swayamjeet Satapathy, Avinash Tupalli, Kunal Ramesh Chandekar, Sanjana Ballal, Chandrasekhar Bal
Radioiodine versus no radioiodine outcomes in low-risk differentiated thyroid cancers: A propensity-score matched analysis. Clinical endocrinology (2023)
Uthara E Mathew, Alpesh Goyal, Ashish D Upadhyay, Devasenathipathy Kandasamy, Shipra Agarwal, Chitresh K Sharma, Arundhati Sharma, Chandrasekhar Bal, Nikhil Tandon, Viveka P Jyotsna
Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism. Clinical endocrinology (2023)
Kunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal
Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma -A systematic review and meta-analysis. Clinical endocrinology (2023)
Bhagwant R Mittal, Althaf K Majeed, Sanjana Ballal, Chandrasekhar Bal
Differentiated thyroid cancers in young adults versus children: Clinical characteristics and ten-year follow-up outcomes. The Journal of clinical endocrinology and metabolism (2023)
Sanjana Ballal, Madhav P Yadav, Swayamjeet Satapathy, Shobhana Raju, Madhavi Tripathi, Nishikant A Damle, Ranjit K Sahoo, Chandrasekhar Bal
Long-term survival outcomes of salvage [ 225 Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study. European journal of nuclear medicine and molecular imaging (2023)
Madhav P Yadav, Sanjana Ballal, Marcel Martin, Frank Roesch, Swayamjeet Satapathy, Euy S Moon, Madhavi Tripathi, Ajay Gogia, Chandrasekhar Bal
Therapeutic potential of [ 177 Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment. European journal of nuclear medicine and molecular imaging (2023)
Sanjana Ballal, Madhav P Yadav, Frank Roesch, Swayamjeet Satapathy, Euy Sung Moon, Marcel Martin, Nicky Wakade, Parvind Sheokand, Madhavi Tripathi, Kunal R Chandekar, Shipra Agarwal, Ranjit Kumar Sahoo, Sameer Rastogi, Chandrasekhar Bal
Head-to-head comparison of [ 68 Ga]Ga-DOTA.SA.FAPi with [ 18 F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers. European journal of nuclear medicine and molecular imaging (2023)
Angel Hemrom, Geetanjali Arora, Nishikant Avinash Damle, Chandrasekhar Bal
Comparative Role of 18 F-DOPA PET/CT and 131 I-MIBG Scintigraphy in Neuroblastoma and Application of Curie and SIOPEN Scoring Systems in 18 F-DOPA PET/CT. Nuclear medicine and molecular imaging 56 (5) (2022)
Althaf K Majeed, Bhagwant R Mittal, Sanjana Ballal, Chandrasekhar Bal
Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers. The Journal of clinical endocrinology and metabolism (2022)
Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, Chandrasekhar Bal
Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study. European journal of nuclear medicine and molecular imaging (2021)
Sanjana Ballal, Madhav Prasad Yadav, Vasko Kramer, Euy Sung Moon, Frank Roesch, Madhav Tripathi, Soumyaranjan Mallick, Sreedharan Thankarajan ArunRaj, Chandrasekhar Bal
A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy. European journal of nuclear medicine and molecular imaging 48 (3) (2020)
Madhav Prasad Yadav, Sanjana Ballal, Marian Meckel, Frank Roesch, Chandrasekhar Bal
[177Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results. EJNMMI research 10 (1) (2020)
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, Vasko S Kramer, Frank Roesch, Samta Kumari, Madhavi Tripathi, Sreedharan Thankarajan ArunRaj, Sulochana Sarswat, Chandrasekhar Bal
Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers. European journal of nuclear medicine and molecular imaging 48 (6) (2020)
Divya Yadav, Sanjana Ballal, Madhav Prasad Yadav, Madhavi Tripathi, Frank Roesch, Chandrasekhar Bal
Evaluation of [68Ga]Ga-DATA-TOC for imaging of neuroendocrine tumours: comparison with [68Ga]Ga-DOTA-NOC PET/CT. European journal of nuclear medicine and molecular imaging 47 (4) (2019)